Wnt signaling in cancer (original) (raw)

• Sharma R . Wingless, a new mutant in D. melanogaster. Drosoph Inf Serv 1973; 50: 134.
  Google Scholar
• Nüsslein-Volhard C, Wieschaus E . Mutations affecting segment number and polarity in Drosophila. Nature 1980; 287: 795–801.
  PubMed Google Scholar
• Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE . Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 1988; 55: 619–625.
  CAS PubMed Google Scholar
• Nusse R, van Ooyen A, Cox D, Fung YK, Varmus H . Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature 307: 131–136.
  CAS PubMed Google Scholar
• Nusse R, Varmus HE . Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982; 31: 99–109.
  CAS PubMed Google Scholar
• Rijsewijk F, Schuermann M, Wagenaar E, Parren P, Weigel D, Nusse R . The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 1987; 50: 649–657.
  CAS PubMed Google Scholar
• McMahon AP, Moon RT . Ectopic expression of the proto-oncogene int-1 in Xenopus embryos leads to duplication of the embryonic axis. Cell 1989; 58: 1075–1084.
  CAS PubMed Google Scholar
• Kinzler K, Nilbert M, Su L, Vogelstein B, Bryan T, Levy D et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253: 661–665.
  CAS PubMed Google Scholar
• Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253: 665–669.
  CAS PubMed Google Scholar
• Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain S, Masiarz F et al. Association of the APC gene product with beta-catenin. Science 1993; 262: 1731–1734.
  CAS PubMed Google Scholar
• Su L, Vogelstein B, Kinzler K . Association of the APC tumor suppressor protein with catenins. Science 1993; 262: 1734–1737.
  CAS PubMed Google Scholar
• Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997; 275: 1784–1787.
  Article CAS PubMed Google Scholar
• Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW . Cancer genome landscapes. Science 2013; 339: 1546–1558.
  Article CAS PubMed PubMed Central Google Scholar
• Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2010; 463: 191–196.
  CAS PubMed Google Scholar
• Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio-Preiser C et al. {beta}-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 2002; 62: 3503–3506.
  CAS PubMed Google Scholar
• Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 2000; 24: 245–250.
  CAS PubMed Google Scholar
• Dahmen RP, Koch A, Denkhaus D, Tonn JC, Sorensen N, Berthold F et al. Deletions of AXIN1, a component of the WNT/wingless pathway, in poradic Medulloblastomas. Cancer Res 2001; 61: 7039–7043.
  CAS PubMed Google Scholar
• Segditsas S, Tomlinson I . Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 2006; 25: 7531–7537.
  CAS PubMed Google Scholar
• Kadowaki T, Wilder E, Klingensmith J, Zachary K, Perrimon N . The segment polarity gene porcupine encodes a putative multitransmembrane protein involved in Wingless processing. Genes Dev 1996; 10: 3116–3128.
  CAS PubMed Google Scholar
• Bartscherer K, Pelte N, Ingelfinger D, Boutros M . Secretion of Wnt ligands requires Evi, a conserved transmembrane protein. Cell 2006; 125: 523–533.
  CAS PubMed Google Scholar
• Bänziger C, Soldini D, Schütt C, Zipperlen P, Hausmann G, Basler K . Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells. Cell 2006; 125: 509–522.
  PubMed Google Scholar
• Yu J, Chia J, Canning CA, Jones CM, Bard FA, Virshup DM . WLS Retrograde transport to the endoplasmic reticulum during Wnt secretion. Dev Cell 2014; 29: 277–291.
  CAS PubMed Google Scholar
• Buechling T, Chaudhary V, Spirohn K, Weiss M, Boutros M . p24 proteins are required for secretion of Wnt ligands. EMBO Rep 2011; 12: 1265–1272.
  CAS PubMed PubMed Central Google Scholar
• Port F, Hausmann G, Basler K . A genome-wide RNA interference screen uncovers two p24 proteins as regulators of Wingless secretion. EMBO Rep 2011; 12: 1144–1152.
  CAS PubMed PubMed Central Google Scholar
• Coudreuse DYM, Roël G, Betist MC, Destrée O, Korswagen HC . Wnt gradient formation requires retromer function in Wnt-producing cells. Science 2006; 312: 921–924.
  CAS PubMed Google Scholar
• Gasnereau I, Herr P, Chia PZC, Basler K, Gleeson PA . Identification of an endocytosis motif in an intracellular loop of Wntless protein, essential for its recycling and the control of Wnt protein signaling. J Biol Chem 2011; 286: 43324–43333.
  CAS PubMed PubMed Central Google Scholar
• Mulligan KA, Fuerer C, Ching W, Fish M, Willert K, Nusse R . Inaugural Article: Secreted Wingless-interacting molecule (Swim) promotes long-range signaling by maintaining Wingless solubility. Proc Natl Acad Sci USA 2012; 109: 370–377.
  CAS PubMed Google Scholar
• Gross JC, Chaudhary V, Bartscherer K, Boutros M . Active Wnt proteins are secreted on exosomes. Nat Cell Biol 2012; 14: 1036–1045.
  CAS PubMed Google Scholar
• Neumann S, Coudreuse DYM, van der Westhuyzen DR, Eckhardt ERM, Korswagen HC, Schmitz G et al. Mammalian Wnt3a is released on lipoprotein particles. Traffic 2009; 10: 334–343.
  CAS PubMed Google Scholar
• Boutros M, Niehrs C . Sticking around: short-range activity of Wnt ligands. Dev Cell 2016; 36: 485–486.
  CAS PubMed Google Scholar
• Farin HF, Jordens I, Mosa MH, Basak O, Korving J, Tauriello DVF et al. Visualization of a short-range Wnt gradient in the intestinal stem-cell niche. Nature 2016; 530: 340–343.
  CAS PubMed Google Scholar
• Koch S, Acebron SP, Herbst J, Hatiboglu G, Niehrs C . Post-transcriptional Wnt signaling governs epididymal sperm maturation. Cell 2015; 163: 1225–1236.
  CAS PubMed Google Scholar
• Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 2012; 151: 1542–1556.
  CAS PubMed Google Scholar
• Kazanskaya O, Glinka A, del Barco Barrantes I, Stannek P, Niehrs C, Wu W . R-Spondin2 is a secreted activator of Wnt/b-catenin signaling and is required for Xenopus myogenesis. Dev Cell 2004; 7: 525–534.
  CAS PubMed Google Scholar
• Glinka A, Dolde C, Kirsch N, Huang Y-L, Kazanskaya O, Ingelfinger D et al. LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and Wnt/PCP signalling. EMBO Rep 2011; 12: 1055–1061.
  CAS PubMed PubMed Central Google Scholar
• Hao H-X, Xie Y, Zhang Y, Charlat O, Oster E, Avello M et al. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 2012; 485: 195–200.
  CAS PubMed Google Scholar
• de Lau W, Barker N, Low TY, Koo B-K, Li VSW, Teunissen H et al. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 2011; 476: 293–297.
  CAS PubMed Google Scholar
• De Lau W, Peng WC, Gros P, Clevers H . The R-spondin / Lgr5 / Rnf43 module: regulator of Wnt signal strength the R-spondin / Lgr5 / Rnf43 module: regulator of Wnt signal strength. Genes Dev 2014; 28: 305–316.
  Google Scholar
• Koo B-K, Spit M, Jordens I, Low TY, Stange DE, van de Wetering M et al. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 2012; 488: 665–669.
  CAS PubMed Google Scholar
• Jiang X, Charlat O, Zamponi R, Yang Y, Cong F . Dishevelled promotes Wnt receptor degradation through recruitment of ZNRF3/RNF43 E3 ubiquitin ligases. Mol Cell 2015; 58: 522–533.
  CAS PubMed Google Scholar
• Giannakis M, Hodis E, Jasmine Mu X, Yamauchi M, Rosenbluh J, Cibulskis K et al. RNF43 is frequently mutated in colorectal and endometrial cancers. Nat Genet 2014; 46: 1264–1266.
  CAS PubMed PubMed Central Google Scholar
• Jiang X, Hao H-X, Growney JD, Woolfenden S, Bottiglio C, Ng N et al. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma. Proc Natl Acad Sci USA 2013; 110: 12649–12654.
  CAS PubMed PubMed Central Google Scholar
• Azzolin L, Panciera T, Soligo S, Enzo E, Bicciato S, Dupont S et al. YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response. Cell 2014; 158: 157–170.
  CAS PubMed Google Scholar
• Barry ER, Morikawa T, Butler BL, Shrestha K, de la Rosa R, Yan KS et al. Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 2012; 493: 106–110.
  CAS PubMed PubMed Central Google Scholar
• Varelas X, Miller BW, Sopko R, Song S, Gregorieff A, Fellouse FA et al. The Hippo pathway regulates Wnt/β-catenin signaling. Dev Cell 2010; 18: 579–591.
  CAS PubMed Google Scholar
• Heallen T, Zhang M, Wang J, Bonilla-claudio M, Klysik E, Randy L et al. NIH public access. Science 2012; 332: 458–461.
  Google Scholar
• Rosenbluh J, Nijhawan D, Cox AG, Li X, James T, Schafer EJ et al. NIH public access. Cell 2013; 151: 1457–1473.
  Google Scholar
• Lien WH, Fuchs E . Wnt some lose some: transcriptional governance of stem cells by Wnt/β-catenin signaling. Genes Dev 2014; 28: 1517–1532.
  CAS PubMed PubMed Central Google Scholar
• MacDonald BT, Tamai K, He X . Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009; 17: 9–26.
  Article CAS PubMed PubMed Central Google Scholar
• Li J, Chen X, Ding X, Cheng Y, Zhao B, Lai ZC et al. LATS2 suppresses oncogenic Wnt signaling by disrupting β-Catenin/BCL9 interaction. Cell Rep 2013; 5: 1650–1663.
  CAS PubMed PubMed Central Google Scholar
• Takada K, Zhu D, Bird GH, Sukhdeo K, Zhao J-J, Mani M et al. Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling. Sci Transl Med 2012; 4: 148ra117.
  PubMed PubMed Central Google Scholar
• Jung H-Y, Jun S, Lee M, Kim H-C, Wang X, Ji H et al. PAF and EZH2 induce Wnt/β-catenin signaling hyperactivation. Mol Cell 2013; 52: 193–205.
  CAS PubMed PubMed Central Google Scholar
• Davidson G, Shen J, Huang Y-L, Su Y, Karaulanov E, Bartscherer K et al. Cell cycle control of wnt receptor activation. Dev Cell 2009; 17: 788–799.
  CAS PubMed Google Scholar
• Acebron SP, Karaulanov E, Berger BS, Huang Y-L, Niehrs C . Mitotic Wnt signaling promotes protein stabilization and regulates cell size. Mol Cell 2014; 54: 663–674.
  CAS PubMed Google Scholar
• Taelman VF, Dobrowolski R, Plouhinec J-L, Fuentealba LC, Vorwald PP, Gumper I et al. Wnt Signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 2010; 143: 1136–1148.
  CAS PubMed PubMed Central Google Scholar
• Xu C, Kim NG, Gumbiner BM . Regulation of protein stability by GSK3 mediated phosphorylation. Cell Cycle 2009; 8: 4032–4039.
  CAS PubMed Google Scholar
• Stolz A, Neufeld K, Ertych N, Bastians H . Wnt-mediated protein stabilization ensures proper mitotic microtubule assembly and chromosome segregation. EMBO Rep 2015; 16: 490–499.
  CAS PubMed PubMed Central Google Scholar
• Huang Y-L, Anvarian Z, Döderlein G, Acebron SP, Niehrs C . Maternal Wnt/STOP signaling promotes cell division during early Xenopus embryogenesis. Proc Natl Acad Sci USA 2015; 112: 5732–5737.
  CAS PubMed PubMed Central Google Scholar
• Ploper D, Taelman VF, Robert L, Perez BS, Titz B, Chen H-W et al. MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells. Proc Natl Acad Sci USA 2015; 112: E420–E429.
  CAS PubMed PubMed Central Google Scholar
• Anastas JN, Moon RT . WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 2013; 13: 11–26.
  CAS PubMed Google Scholar
• Wang Y . Wnt/Planar cell polarity signaling: a new paradigm for cancer therapy. Mol Cancer Ther 2009; 8: 2103–2109.
  CAS PubMed Google Scholar
• Katoh M . WNT/PCP signaling pathway and human cancer (Review). Oncol Rep 2005; 14: 1583–1588.
  CAS PubMed Google Scholar
• De A . Wnt/Ca2+ signaling pathway: a brief overview. Acta Biochim Biophys Sin (Shanghai) 2011; 43: 745–756.
  CAS Google Scholar
• Yang Y, Mlodzik M . Wnt-frizzled/planar cell polarity signaling: cellular orientation by facing the wind (Wnt). Annu Rev Cell Dev Biol 2015; 31: 623–646.
  PubMed PubMed Central Google Scholar
• Nomachi A, Nishita M, Inaba D, Enomoto M, Hamasaki M, Minami Y . Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A. J Biol Chem 2008; 283: 27973–27981.
  CAS PubMed Google Scholar
• Endo M, Nishita M, Fujii M, Minami Y . Insight into the role of Wnt5a-induced signaling in normal and cancer cells. Int Rev Cell Mol Biol 2015; 314: 117–148.
  PubMed Google Scholar
• Polakis P . Wnt signaling in cancer. Cold Spring Harb Perspect Biol 2012; 4: 9.
  Google Scholar
• Matano M, Date S, Shimokawa M, Takano A, Fujii M, Ohta Y et al. Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids. Nat Med 2015; 21: 256–262.
  CAS PubMed Google Scholar
• Drost J, van Jaarsveld RH, Ponsioen B, Zimberlin C, van Boxtel R, Buijs A et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature 2015; 521: 43–47.
  CAS PubMed Google Scholar
• Christie M, Jorissen RN, Mouradov D, Sakthianandeswaren A, Li S, Day F et al. Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis. Oncogene 2013; 32: 4675–4682.
  CAS PubMed Google Scholar
• Buchert M, Athineos D, Abud HE, Burke ZD, Faux MC, Samuel MS et al. Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo. PLoS Genet 2010; 6: e1000816.
  PubMed PubMed Central Google Scholar
• Dow LE, O’Rourke KP, Simon J, Tschaharganeh DF, van Es JH, Clevers H et al. Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer. Cell 2015; 161: 1539–1552.
  CAS PubMed PubMed Central Google Scholar
• Voloshanenko O, Erdmann G, Dubash TD, Augustin I, Metzig M, Moffa G et al. Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells. Nat Commun 2013; 4: 2610.
  PubMed Google Scholar
• Guinney J, Dienstmann R, Wang X, de Reyniès A, Schlicker A, Soneson C et al. The consensus molecular subtypes of colorectal cancer. Nat Med 2015; 21: 1350–1356.
  CAS PubMed PubMed Central Google Scholar
• Seshagiri S, Stawiski EW, Durinck S, Modrusan Z, Storm EE, Conboy CB et al. Recurrent R-spondin fusions in colon cancer. Nature 2012; 488: 660–664.
  CAS PubMed PubMed Central Google Scholar
• van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A et al. Prospective derivation of a living organoid Biobank of colorectal cancer patients. Cell 2015; 161: 933–945.
  CAS PubMed PubMed Central Google Scholar
• Rusan NM, Peifer M . Original CIN: reviewing roles for APC in chromosome instability. J Cell Biol 2008; 181: 719–726.
  CAS PubMed PubMed Central Google Scholar
• Caldwell CM, Green RA, Kaplan KB . APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice. J Cell Biol 2007; 178: 1109–1120.
  CAS PubMed PubMed Central Google Scholar
• Aoki K, Aoki M, Sugai M, Harada N, Miyoshi H, Tsukamoto T et al. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells. Oncogene 2007; 26: 3511–3520.
  CAS PubMed Google Scholar
• Ertych N, Stolz A, Stenzinger A, Weichert W, Kaulfuß S, Burfeind P et al. Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells. Nat Cell Biol 2014; 16: 779–791.
  CAS PubMed PubMed Central Google Scholar
• Zeng G, Germinaro M, Micsenyi A, Monga NK, Bell A, Sood A et al. Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma. Neoplasia 2006; 8: 279–289.
  CAS PubMed PubMed Central Google Scholar
• White BD, Chien AJ, Dawson DW . Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers. Gastroenterology 2012; 142: 219–232.
  CAS PubMed Google Scholar
• Morris JP, Cano DA, Sekine S, Wang SC, Hebrok M . Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. J Clin Invest 2010; 120: 508–520.
  CAS PubMed PubMed Central Google Scholar
• Zhang Y, Morris JP, Yan W, Schofield HK, Gurney A, Simeone DM et al. Canonical Wnt signaling is required for pancreatic carcinogenesis. Cancer Res 2013; 73: 4909–4922.
  CAS PubMed PubMed Central Google Scholar
• Dougherty DM, Marsh-richard DM, Hatzis ES, Nouvion SO, Mathias CW . WNT7B mediates autocrine Wnt/β-catenin signaling and anchorage-independent growth in pancreatic adenocarcinoma. Oncogene 2014; 96: 111–120.
  Google Scholar
• Boulter L, Guest R V, Kendall TJ, Wilson DH, Wojtacha D, Robson AJ et al. WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited. J Clin Invest 2015; 125: 1269–1285.
  PubMed PubMed Central Google Scholar
• Loilome W, Bungkanjana P, Techasen A, Namwat N, Yongvanit P, Puapairoj A et al. Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells. Tumour Biol 2014; 35: 5357–5367.
  CAS PubMed Google Scholar
• Chan-On W, Nairismägi M-L, Ong CK, Lim WK, Dima S, Pairojkul C et al. Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. Nat Genet 2013; 45: 1474–1478.
  CAS PubMed Google Scholar
• Goeppert B, Konermann C, Schmidt CR, Bogatyrova O, Geiselhart L, Ernst C et al. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway. Hepatology 2014; 59: 544–554.
  CAS PubMed Google Scholar
• Luis TC, Ichii M, Brugman MH, Kincade P, Staal FJT . Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development. Leukemia 2012; 26: 414–421.
  CAS PubMed Google Scholar
• Lento W, Congdon K, Voermans C, Kritzik M, Reya T . Wnt signaling in normal and malignant hematopoiesis. Cold Spring Harb Perspect Biol e-pub ahead of print 1 February 2013 doi:10.1101/cshperspect.a008011.
  PubMed PubMed Central Google Scholar
• Yeung J, Esposito MT, Gandillet A, Zeisig BB, Griessinger E, Bonnet D et al. β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells. Cancer Cell 2010; 18: 606–618.
  CAS PubMed Google Scholar
• Lane SW, Wang YJ, Lo Celso C, Ragu C, Bullinger L, Stephen M et al. Differential niche and Wnt requirements during acute myeloid leukemia progression. Blood 2011; 118: 2849–2856.
  CAS PubMed PubMed Central Google Scholar
• Wang Y, Krivtsov A, Sinha A, North T . The Wnt/β-catenin pathway is required for the development of leukemia stem cells in AML. Science 2010; 327: 1650–1653.
  CAS PubMed PubMed Central Google Scholar
• Yeung J, Esposito MT, Gandillet A, Zeisig BB, Griessinger E, Bonnet D et al. Beta-catenin mediates the establishment and drug resistance of MLL leukemic stem cells. Cancer Cell 2010; 18: 606–618.
  CAS PubMed Google Scholar
• Cheng CK, Li L, Cheng SH, Lau KM, Chan NPH, Wong RSM et al. Transcriptional repression of the RUNX3/AML2 gene by the t(8;21) and inv(16) fusion proteins in acute myeloid leukemia. Blood 2008; 112: 3391–3402.
  CAS PubMed Google Scholar
• Müller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S et al. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol Cell Biol 2004; 24: 2890–2904.
  PubMed PubMed Central Google Scholar
• Ferrando AA . The role of NOTCH1 signaling in T-ALL. Hematology Am Soc Hematol Educ Program 2009; 2009: 353–361.
  Google Scholar
• Guo W, Lasky JL, Chang C-J, Mosessian S, Lewis X, Xiao Y et al. Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation. Nature 2008; 453: 529–533.
  CAS PubMed PubMed Central Google Scholar
• Kaveri D, Kastner P, Dembélé D, Nerlov C, Chan S, Kirstetter P . β-Catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL. Blood 2013; 122: 694–704.
  CAS PubMed Google Scholar
• Giambra V, Jenkins CE, Lam SH, Hoofd C, Belmonte M, Wang X et al. Leukemia stem cells in T-ALL require active Hif1α and Wnt signaling. Blood 2015; 125: 3917–3927.
  CAS PubMed PubMed Central Google Scholar
• Lu D, Zhao Y, Tawatao R, Cottam HB, Sen M, Leoni LM et al. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2004; 101: 3118–3123.
  CAS PubMed PubMed Central Google Scholar
• Moskalev EA, Luckert K, Vorobjev IA, Mastitsky SE, Gladkikh AA, Stephan A et al. Concurrent epigenetic silencing of wnt / β -catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia. BMC Cancer 2012; 12: 1.
  Google Scholar
• Wang L, Shalek AK, Lawrence M, Ding R, Gaublomme JT, Pochet N et al. Somatic mutation as a mechanism of Wnt/beta-catenin pathway activation in CLL. Blood 2014; 124: 1089–1098.
  CAS PubMed PubMed Central Google Scholar
• Stolz W, Schmoeckel C, Landthaler M, Braun-Falco O . Association of early malignant melanoma with nevocytic nevi. Cancer 1989; 63: 550–555.
  CAS PubMed Google Scholar
• Dhomen N, Reis-Filho JS, da Rocha Dias S, Hayward R, Savage K, Delmas V et al. Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell 2009; 15: 294–303.
  CAS PubMed Google Scholar
• Jones SL, Cichowski K . Many roads lead to oncogene-induced senescence. Oncogene 2008; 27: 2801–2809.
  PubMed Google Scholar
• Delmas V, Beermann F, Martinozzi S, Carreira S, Ackermann J, Kumasaka M et al. Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev 2007; 21: 2923–2935.
  CAS PubMed PubMed Central Google Scholar
• Juan J, Muraguchi T, Iezza G, Sears RC, McMahon M . Diminished WNT ->beta -catenin->c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors. Genes Dev 2014; 28: 561–575.
  CAS PubMed PubMed Central Google Scholar
• Pawlikowski JS, McBryan T, van Tuyn J, Drotar ME, Hewitt RN, Maier AB et al. Wnt signaling potentiates nevogenesis. Proc Natl Acad Sci USA 2013; 110: 16009–16014.
  CAS PubMed PubMed Central Google Scholar
• Lim X, Nusse R . Wnt signaling in skin development, homeostasis, and disease. Cold Spring Harb Perspect Biol e-pub ahead of print 1 February 2013 doi:10.1101/cshperspect.a008029.
  Google Scholar
• Webster MR, Weeraratna AT . A Wnt-er migration: the confusing role of β-catenin in melanoma metastasis. Sci Signal 2013; 6: pe11.
  PubMed Google Scholar
• Kageshita T, Hamby CV, Ishihara T, Matsumoto K, Saida T, Ono T . Loss of beta-catenin expression associated with disease progression in malignant melanoma. Br J Dermatol 2001; 145: 210–216.
  CAS PubMed Google Scholar
• Bachmann IM . Importance of P-Cadherin, -Catenin, and Wnt5a/Frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clin Cancer Res 2005; 11: 8606–8614.
  CAS PubMed Google Scholar
• Chien AJ, Moore EC, Lonsdorf AS, Kulikauskas RM, Rothberg BG, Berger AJ et al. Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc Natl Acad Sci USA 2009; 106: 1193–1198.
  CAS PubMed PubMed Central Google Scholar
• Damsky WE, Curley DP, Santhanakrishnan M, Rosenbaum LE, Platt JT, Gould Rothberg BE et al. β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. Cancer Cell 2011; 20: 741–754.
  CAS PubMed PubMed Central Google Scholar
• Biechele TL, Kulikauskas RM, Toroni R a, Lucero OM, Swift RD, James RG et al. Wnt/β-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma. Sci Signal 2012; 5: ra3.
  PubMed PubMed Central Google Scholar
• Chien AJ, Haydu LE, Biechele TL, Kulikauskas RM, Rizos H, Kefford RF et al. Targeted BRAF inhibition impacts survival in melanoma patients with high levels of Wnt/β-catenin signaling. PLoS One 2014; 9: e94748.
  PubMed PubMed Central Google Scholar
• O’Connell MP, Fiori JL, Baugher KM, Indig FE, French AD, Camilli TC et al. Wnt5A activates the calpain-mediated cleavage of filamin A. J Invest Dermatol 2009; 129: 1782–1789.
  PubMed PubMed Central Google Scholar
• Webster MR, Xu M, Kinzler KA, Kaur A, Appleton J, Connell MPO et al. Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells. Pigment Cell Melanoma Res 2015; 28: 184–195.
  CAS PubMed Google Scholar
• Anastas JN, Kulikauskas RM, Tamir T, Rizos H, Long G V, von Euw EM et al. WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors. J Clin Invest 2014; 124: 2877–2890.
  CAS PubMed PubMed Central Google Scholar
• O’Connell MP, Marchbank K, Webster MR, Valiga AA, Kaur A, Vultur A et al. Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2. Cancer Discov 2013; 3: 1378–1393.
  PubMed PubMed Central Google Scholar
• Ekström EJ, Bergenfelz C, von Bülow V, Serifler F, Carlemalm E, Jönsson G et al. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells. Mol Cancer 2014; 13: 1–15.
  Google Scholar
• Linnskog R, Jönsson G, Axelsson L, Prasad CP, Andersson T . Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression. Mol Oncol 2014; 8: 1365–1378.
  CAS PubMed PubMed Central Google Scholar
• Grossmann AH, Yoo JH, Clancy J, Sorensen LK, Sedgwick A, Tong Z et al. The small GTPase ARF6 stimulates β-catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasis. Sci Signal 2013; 6: ra14.
  PubMed PubMed Central Google Scholar
• Mikels AJ, Nusse R . Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 2006; 4: e115.
  PubMed PubMed Central Google Scholar
• Hoek KS, Schlegel NC, Brafford P, Sucker A, Ugurel S, Kumar R et al. Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res 2006; 19: 290–302.
  CAS PubMed Google Scholar
• Hoek KS, Eichhoff OM, Schlegel NC, Döbbeling U, Kobert N, Schaerer L et al. In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res 2008; 68: 650–656.
  CAS PubMed Google Scholar
• Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y et al. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 2000; 97: 4262–4266.
  CAS PubMed PubMed Central Google Scholar
• Geyer FC, Lacroix-Triki M, Savage K, Arnedos M, Lambros MB, MacKay A et al. β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation. Mod Pathol 2011; 24: 209–231.
  CAS PubMed Google Scholar
• Khramtsov AI, Khramtsova GF, Tretiakova M, Huo D, Olopade OI, Goss KH . Wnt/{beta}-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol 2010; 176: 2911–2920.
  PubMed PubMed Central Google Scholar
• Xu J, Prosperi JR, Choudhury N, Olopade OI, Goss KH . B-catenin is required for the tumorigenic behavior of triple-negative breast cancer cells. PLoS One 2015; 10: 1–11.
  Google Scholar
• Li S, Li S, Sun Y, Li L . The expression of β-catenin in different subtypes of breast cancer and its clinical significance. Tumour Biol 2014; 35: 7693–7698.
  CAS PubMed Google Scholar
• Howe LR, Brown AMC . Wnt signaling and breast cancer. Cancer Biol Ther 2004; 3: 36–41.
  CAS PubMed Google Scholar
• Liu C-C, Prior J, Piwnica-Worms D, Bu G . LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy. Proc Natl Acad Sci USA 2010; 107: 5136–5141.
  CAS PubMed PubMed Central Google Scholar
• Yang L, Wu X, Wang Y, Zhang K, Wu J, Yuan Y-C et al. FZD7 has a critical role in cell proliferation in triple negative breast cancer. Oncogene 2011; 30: 4437–4446.
  CAS PubMed Google Scholar
• Klarmann GJ, Decker A, Farrar WL . Epigenetic gene silencing in the Wnt pathway in breast cancer. Epigenetics 2008; 3: 59–63.
  PubMed Google Scholar
• Gunther EJ, Moody SE, Belka GK, Hahn KT, Innocent N, Dugan KD et al. Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes Dev 2003; 17: 488–501.
  CAS PubMed PubMed Central Google Scholar
• Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci USA 2003; 100: 15853–15858.
  CAS PubMed PubMed Central Google Scholar
• Klauzinska M, Baljinnyam B, Raafat A, Rodriguez-Canales J, Strizzi L, Endo Greer Y et al. Rspo2/Int7 regulates invasiveness and tumorigenic properties of mammary epithelial cells. J Cell Physiol 2012; 227: 1960–1971.
  CAS PubMed PubMed Central Google Scholar
• Cleary AS, Leonard TL, Gestl SA, Gunther EJ . Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers. Nature 2014; 508: 113–117.
  CAS PubMed PubMed Central Google Scholar
• Kim S, Goel S, Alexander CM . Differentiation generates paracrine cell pairs that maintain basaloid mouse mammary tumors: proof of concept. PLoS One 2011; 6: e19310.
  CAS PubMed PubMed Central Google Scholar
• Beck B, Blanpain C . Unravelling cancer stem cell potential. Nat Rev Cancer 2013; 13: 727–738.
  CAS PubMed Google Scholar
• Reya T, Clevers H . Wnt signalling in stem cells and cancer. Nature 2005; 434: 843–850.
  CAS PubMed Google Scholar
• Park J-I, Venteicher AS, Hong JY, Choi J, Jun S, Shkreli M et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 2009; 460: 66–72.
  CAS PubMed PubMed Central Google Scholar
• Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2008; 457: 608–611.
  PubMed Google Scholar
• Schepers AG, Snippert HJ, Stange DE, van den Born M, van Es JH, van de Wetering M et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 2012; 337: 730–735.
  CAS PubMed Google Scholar
• Myant KB, Cammareri P, McGhee EJ, Ridgway RA, Huels DJ, Cordero JB et al. ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell 2013; 12: 761–773.
  CAS PubMed PubMed Central Google Scholar
• Schwitalla S, Fingerle AA, Cammareri P, Nebelsiek T, Göktuna SI, Ziegler PK et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 2013; 152: 25–38.
  CAS PubMed Google Scholar
• Vermeulen L, De Sousa E, Melo F, van der Heijden M, Cameron K, de Jong JH, Borovski T et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010; 12: 468–476.
  CAS PubMed Google Scholar
• Malanchi I, Santamaria-Martínez A, Susanto E, Peng H, Lehr H-A, Delaloye J-F et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 2012; 481: 85–89.
  CAS Google Scholar
• Kessenbrock K, Dijkgraaf GJP, Lawson DA, Littlepage LE, Shahi P, Pieper U et al. A role for matrix metalloproteinases in regulating mammary stem cell function via the Wnt signaling pathway. Cell Stem Cell 2013; 13: 300–313.
  CAS PubMed PubMed Central Google Scholar
• Todaro M, Gaggianesi M, Catalano V, Benfante A, Iovino F, Biffoni M et al. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell 2014; 14: 342–356.
  CAS PubMed Google Scholar
• Hwang W-L, Jiang J-K, Yang S-H, Huang T-S, Lan H-Y, Teng H-W et al. MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol 2014; 16: 268–280.
  CAS PubMed Google Scholar
• Isobe T, Hisamori S, Hogan DJ, Zabala M, Hendrickson DG, Dalerba P et al. miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway. Elife 2014; 3: 1–23.
  Google Scholar
• Wang Y, He L, Du Y, Zhu P, Huang G, Luo J et al. The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. Cell Stem Cell 2015; 16: 413–425.
  CAS PubMed Google Scholar
• Fang L, Cai J, Chen B, Wu S, Li R, Xu X et al. Aberrantly expressed miR-582-3p maintains lung cancer stem cell-like traits by activating Wnt/β-catenin signalling. Nat Commun 2015; 6: 8640.
  CAS PubMed Google Scholar
• Merlos-Suárez A, Barriga FM, Jung P, Iglesias M, Céspedes MV, Rossell D et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 2011; 8: 511–524.
  PubMed Google Scholar
• de Sousa E, Melo F, Colak S, Buikhuisen J, Koster J, Cameron K, de Jong JH et al. Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell 2011; 9: 476–485.
  Google Scholar
• Scheel C, Weinberg RA . Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol 2012; 22: 396–403.
  CAS PubMed PubMed Central Google Scholar
• Kalluri R . EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 2009; 119: 1417–1419.
  CAS PubMed PubMed Central Google Scholar
• De Craene B, Berx G . Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 2013; 13: 97–110.
  CAS PubMed Google Scholar
• Wu Z-Q, Li X-Y, Hu CY, Ford M, Kleer CG, Weiss SJ . Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression. Proc Natl Acad Sci USA 2012; 109: 16654–16659.
  CAS PubMed PubMed Central Google Scholar
• Wang Y, Bu F, Royer C, Serres S, Larkin JR, Soto MS et al. ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1. Nat Cell Biol 2014; 16: 1092–1104.
  CAS PubMed Google Scholar
• Tenbaum SP, Ordóñez-Morán P, Puig I, Chicote I, Arqués O, Landolfi S et al. β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat Med 2012; 18: 892–901.
  CAS PubMed Google Scholar
• Gujral TS, Chan M, Peshkin L, Sorger PK, Kirschner MW, MacBeath G . A Noncanonical frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis. Cell 2014; 159: 844–856.
  CAS PubMed PubMed Central Google Scholar
• Kahlert C, Kalluri R . Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl) 2013; 91: 431–437.
  CAS Google Scholar
• Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ . Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol 2010; 190: 1079–1091.
  CAS PubMed PubMed Central Google Scholar
• Luga V, Zhang L, Viloria-Petit AM, Ogunjimi A a, Inanlou MR, Chiu E et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 2012; 151: 1542–1556.
  CAS PubMed Google Scholar
• Maheswaran S, Haber DA . Circulating tumor cells: a window into cancer biology and metastasis. Curr Opin Genet Dev 2010; 20: 96–99.
  CAS PubMed PubMed Central Google Scholar
• Yu M, Ting DT, Stott SL, Wittner BS, Ozsolak F, Paul S et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature 2012; 487: 510–513.
  CAS PubMed PubMed Central Google Scholar
• Miyamoto DT, Zheng Y, Wittner BS, Lee RJ, Zhu H, Broderick KT et al. RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. Science 2015; 349: 1351–1356.
  CAS PubMed PubMed Central Google Scholar
• Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Cowey CL, Lao CD et al. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med 2015; 373: 23–34.
  PubMed PubMed Central Google Scholar
• Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med 2015; 373: 1627–1639.
  CAS PubMed PubMed Central Google Scholar
• Motzer RJ, Escudier B, McDermott DF, George S, Hammers HJ, Srinivas S et al. Nivolumab versus everolimus in advanced renal-cell carcinoma. N Engl J Med 2015; 373: 1803–1813.
  CAS PubMed PubMed Central Google Scholar
• Staal FJT, Luis TC, Tiemessen MM . WNT signalling in the immune system: WNT is spreading its wings. Nat Rev Immunol 2008; 8: 581–593.
  CAS PubMed Google Scholar
• Spranger S, Bao R, Gajewski TF . Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity. Nature 2015; 523: 231–235.
  CAS PubMed Google Scholar
• Yaguchi T, Goto Y, Kido K, Mochimaru H, Sakurai T, Tsukamoto N et al. Immune suppression and resistance mediated by constitutive activation of Wnt/β-catenin signaling in human melanoma cells. J Immunol 2012; 189: 2110–2117.
  CAS PubMed Google Scholar
• Malladi S, Macalinao DG, Jin X, He L, Basnet H, Zou Y et al. Metastatic latency and immune evasion through autocrine inhibition of WNT. Cell 2016; 165: 45–60.
  CAS PubMed PubMed Central Google Scholar
• Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med 2015; 372: 2509–2520.
  CAS PubMed PubMed Central Google Scholar
• Kahn M . Can we safely target the WNT pathway? Nat Rev Drug Discov 2014; 13: 513–532.
  CAS PubMed PubMed Central Google Scholar
• Dodge ME, Moon J, Tuladhar R, Lu J, Jacob LS, Zhang L et al. Diverse chemical scaffolds support direct inhibition of the membrane-bound O-acyltransferase porcupine. J Biol Chem 2012; 287: 23246–23254.
  CAS PubMed PubMed Central Google Scholar
• van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 2015; 161: 933–945.
  CAS PubMed PubMed Central Google Scholar
• Madan B, Ke Z, Harmston N, Ho SY, Frois AO, Alam J et al. Wnt addiction of genetically defined cancers reversed by PORCN inhibition. Oncogene 2016; 35: 2197–2207.
  CAS PubMed Google Scholar
• D3 (Drug Product and Development) BSI. A Study to Evaluate the Safety and Tolerability of ETC-1922159 in Advanced Solid Tumours. ClinicalTrials.gov, 2015, p NCT02521844.
• Yeung P, Beviglia L, Cancilla B, Dee-Hoskins C, Evans JW, Fischer MM et al. Abstract 1907: Wnt pathway antagonist OMP-54F28 (FZD8-Fc) inhibits tumor growth and reduces tumor-initiating cell frequency in patient-derived hepatocellular carcinoma and ovarian cancer xenograft models. Cancer Res 2014; 74: 1907–1907.
  Google Scholar
• Gurney A, Axelrod F, Bond CJ, Cain J, Chartier C, Donigan L et al. Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors. Proc Natl Acad Sci USA 2012; 109: 11717–11722.
  CAS PubMed PubMed Central Google Scholar
• Smith DC, Rosen LS, Chugh R, Goldman JW, Xu L, Kapoun A et al. General Poster Session (Board # 1H), Mon, 8: 00 AM-11: 45 AM First-in-human evaluation of the human monoclonal antibody vantictumab (OMP- 18R5; anti-Frizzled) targeting the WNT pathway in a phase I study for patients with advanced solid tumors. ASCO Annu Meet Abstr 2013; J Clin Onc: 1345201.
• Baron R, Kneissel M . WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 2013; 19: 179–192.
  CAS PubMed Google Scholar
• Nagayama S, Yamada E, Kohno Y, Aoyama T, Fukukawa C, Kubo H et al. Inverse correlation of the up-regulation of FZD10 expression and the activation of beta-catenin in synchronous colorectal tumors. Cancer Sci 2009; 100: 405–412.
  CAS PubMed Google Scholar
• Giraudet A-L, Badel J-N, Cassier P, Desuzinges C, Kriza D, Perol D et al. SYNFRIZZ-A phase Ia/Ib of a radiolabelled monoclonal AB for the treatment of relapsing synovial sarcoma. J Nucl Med 2014; 55: 223.
  Google Scholar
• Gang EJ, Hsieh Y-T, Pham J, Zhao Y, Nguyen C, Huantes S et al. Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia. Oncogene 2014; 33: 2169–2178.
  CAS PubMed Google Scholar
• Rebel VI, Kung AL, Tanner EA, Yang H, Bronson RT, Livingston DM . Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. Proc Natl Acad Sci USA 2002; 99: 14789–14794.
  CAS PubMed PubMed Central Google Scholar
• Robert R, McWilliams, Andrew H, Ko E, Gabriela Chiorean, Eunice Lee Kwak et al. A phase Ib dose-escalation study of PRI-724, a CBP/beta-catenin modulator, plus gemcitabine (GEM) in patients with advanced pancreatic adenocarcinoma (APC) as second-line therapy after FOLFIRINOX or FOLFOX. J Clin Oncol 2015; 33: abstr e15270.
  Google Scholar
• University of Southern California. Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer (PRIMIER). In: Clinicaltrials.Gov. 2015, p NCT02413853.
• Huang S-MA, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 2009; 461: 614–620.
  CAS PubMed Google Scholar
• Riffell JL, Lord CJ, Ashworth A . Tankyrase-targeted therapeutics: expanding opportunities in the PARP family. Nat Rev Drug Discov 2012; 11: 923–936.
  CAS PubMed Google Scholar
• Lau T, Chan E, Callow M, Waaler J, Boggs J, Blake RA et al. A novel Tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth. Cancer Res 2013; 73: 3132–3144.
  CAS PubMed Google Scholar
• Andersson T, Axelsson L, Mohapatra P, Prasad C, Soerensen PG, Mau-Soerensen M et al. Abstract A116: targeting the Wnt-5a signaling pathway as a novel anti-metastatic therapy. Mol Cancer Ther 2015; 14: A116–A116.
  Google Scholar
• Latres E, Chiaur DS, Pagano M . The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin. Oncogene 1999; 18: 849–854.
  CAS PubMed Google Scholar
• Metcalfe C, Mendoza-Topaz C, Mieszczanek J, Bienz M . Stability elements in the LRP6 cytoplasmic tail confer efficient signalling upon DIX-dependent polymerization. J Cell Sci 2010; 123: 1588–1599.
  CAS PubMed PubMed Central Google Scholar
• Clevers H . Wnt/Beta-catenin signaling in development and disease. Cell 2006; 127: 469–480.
  CAS PubMed Google Scholar
• Tree DRP, Shulman JM, Scott MP, Gubb D, Axelrod JD . Prickle mediates feedback amplification to generate asymmetric planar cell polarity signaling. Cell 2002; 109: 371–381.
  CAS PubMed Google Scholar
• Habas R, Kato Y, He X . Wnt / frizzled activation of Rho regulates vertebrate gastrulation and requires a novel formin homology protein Daam1. Cell 2001; 107: 843–854.
  CAS PubMed Google Scholar
• Kikuchi A, Yamamoto H, Sato A, Matsumoto S . New insights into the mechanism of Wnt signaling pathway activation. Int Rev Cell Mol Biol 2011; 291: 21–71.
  CAS PubMed Google Scholar
• Gao B, Song H, Bishop K, Elliot G, Garrett L, English MA et al. Wnt signaling gradients establish planar cell polarity by inducing Vangl2 phosphorylation through Ror2. Dev Cell 2011; 20: 163–176.
  CAS PubMed PubMed Central Google Scholar
• Gao C, Chen Y . Dishevelled: the hub of Wnt signaling. Cell Signal 2010; 22: 717–727.
  CAS PubMed Google Scholar
• Sheldahl LC, Slusarski DC, Pandur P, Miller JR, Kuhl M, Moon RT . Dishevelled activates Ca2+ flux, PKC, and CamKII in vertebrate embryos. J Cell Biol 2003; 161: 769–777.
  CAS PubMed PubMed Central Google Scholar
• Zhang C, Cattaruzza F, Yeung P, Yen W-C, Fischer M, Brunner A et al. Abstract A30: Predictive and pharmacodynamic biomarkers of vantictumab (OMP-18R5; anti-Frizzled) in non-small cell lung cancer. Mol Cancer Ther 2015; 14: A30–A30.
  Google Scholar